Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adherence to Lenalidomide Treatment in Multiple Myeloma - Prevalence, Characteristics and Clinical Significance

NCT02733224 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT02733224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02733224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adherence to Lenalidomide Treatment in Multiple Myeloma - Prevalence, Characteristics and Clinical Significance
Lead sponsor
Rabin Medical Center
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2016
Completion date
August 31, 2018
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

patient non-adherence